Based on these findings, a synergism between synuclein and Alzheimer’s disease-type pathologies [primarily amyloid deposits (Aβ) pathology] to dementia-risk in Lewy Body Diseases is conceivable.22 This evidence concerns the gene SNCA and dementia.